Tirzepatide Versus Long-Acting Insulin: A Systematic Review and Meta-Analysis | ||
| Egyptian Society of Diabetes and Lipidology Journal | ||
| Volume 4, Issue 2, October 2024 PDF (1.36 M) | ||
| Document Type: Abstracts | ||
| DOI: 10.21608/esdlj.2024.456243 | ||
| Abstract | ||
| Tirzepatide, a dual GIP and GLP-1 receptor agonist, is a promising treatment for type 2 diabetes mellitus (T2DM). We aim to assess the efficacy and safety of Tirzepatide compared to long-acting insulin in T2DM patients. | ||
|
Statistics Article View: 25 PDF Download: 10 |
||
